Bosentan in mild pulmonary hypertension

The Lancet

Volumn 372, Issue 9651, 2008, Pages 1730-

  van der Plas, Mart N ^a   Duffels, Mariëlle GJ ^a   Ponse, Dikyi ^a   Mulder, Barbara JM ^a   Bresser, Paul ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; ANTIHYPERTENSIVE AGENT; SULFONAMIDE;

AEROBIC CAPACITY; CARDIOPULMONARY EXERCISE TEST; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; HEART HEMODYNAMICS; HUMAN; LETTER; LUNG VASCULAR RESISTANCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; CLASSIFICATION; DRUG EFFECT; HOSPITALIZATION; NOTE; VASCULAR RESISTANCE; WALKING;

ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION, PULMONARY; SEVERITY OF ILLNESS INDEX; SULFONAMIDES; VASCULAR RESISTANCE; WALKING;

EID: 55749108845     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61725-0     Document Type: Letter

References (5)

1. Galie N., Rubin L.J., Hoeper M.M., et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet 371 (2008) 2093-2100
2. Holverda S., Gan C.T., Marcus J.T., Postmus P.E., Boonstra A., and Vonk-Noordegraaf A. Impaired stroke volume response to exercise in pulmonary arterial hypertension. J Am Coll Cardiol 47 (2006) 1732-1733
3. Raeside D.A., Smith A., Brown A., et al. Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension. Eur Respir J 16 (2000) 282-287
4. Barst R.J., Langleben D., Frost A., et al. Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med 169 (2004) 441-447
5. van der Plas M.N., Ponse D., Duffels M., van Steenwijk R.P., Sterk P.J., and Bresser P. Six-minute walk test as a surrogate for CPET to determine aerobic capacity in patients with pulmonary hypertension. Am J Respir Crit Care Med 177 (2008) A923